{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:28:56Z","timestamp":1787729336274,"version":"build-2784847793"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1124\/jpet.119.259390","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:22:44Z","timestamp":1569630164000},"page":"602-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats"],"prefix":"10.1016","volume":"371","author":[{"given":"Chloe J.","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bree A.","family":"Humburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Thorndike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anver Basha","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.259390_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(96)00574-2","article-title":"Cardiovascular effects of cocaine during operant cocaine self-administration","volume":"315","author":"Ambrosio","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.259390_bib2","series-title":"Safety Pharmacology Society","article-title":"An assessment of the cardiovascular safety of the dopamine D3 receptor antagonist GSK598809 with cocaine in telemetered dogs and rats","author":"Appel","year":"2016"},{"key":"10.1124\/jpet.119.259390_bib3","series-title":"Safety Pharmacology Society","article-title":"Cardiovascular safety studies on dopamine D3 receptor antagonists and cocaine","author":"Appel","year":"2017"},{"key":"10.1124\/jpet.119.259390_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/jpet.115.224121","article-title":"Dopamine D3 receptor antagonist (GSK598809) potentiates the hypertensive effects of cocaine in conscious, freely-moving dogs","volume":"354","author":"Appel","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259390_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/cphy.c100032","article-title":"Dopamine and renal function and blood pressure regulation","volume":"1","author":"Armando","year":"2011","journal-title":"Compr Physiol"},{"key":"10.1124\/jpet.119.259390_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/syn.21839","article-title":"The selective dopamine D3 receptor antagonist SB-277011A significantly accelerates extinction to environmental cues associated with cocaine-induced place preference in male Sprague-Dawley rats","volume":"69","author":"Ashby","year":"2015","journal-title":"Synapse"},{"key":"10.1124\/jpet.119.259390_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.119.259390_bib8","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1021\/acs.jmedchem.5b00776","article-title":"High affinity dopamine D3 receptor (D3R)-selective antagonists attenuate heroin self-administration in wild-type but not D3R knockout mice","volume":"58","author":"Boateng","year":"2015","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.259390_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pbb.2010.04.001","article-title":"Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats","volume":"95","author":"Chang","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.119.259390_bib10","first-page":"405","article-title":"Relationship between resting heart rate, blood pressure and pulse pressure in adolescents","volume":"108","author":"Christofaro","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"10.1124\/jpet.119.259390_bib11","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0227-17.2017","article-title":"Dopamine D2 receptors in the paraventricular thalamus attenuate cocaine locomotor sensitization","volume":"4","author":"Clark","year":"2017","journal-title":"eNeuro"},{"key":"10.1124\/jpet.119.259390_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pbb.2016.06.006","article-title":"Sex differences in responsiveness to the prescription opioid oxycodone in mice","volume":"148","author":"Collins","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.119.259390_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.pa.17.040177.002013","article-title":"Pharmacologic control of temperature regulation","volume":"17","author":"Cox","year":"1977","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.119.259390_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(00)00260-0","article-title":"Gender differences in the cardiovascular responses to morphine and naloxone in spinal rats","volume":"397","author":"Cruz","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.259390_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1358\/dot.2016.52.2.2461868","article-title":"Cariprazine: new dopamine biased agonist for neuropsychiatric disorders","volume":"52","author":"De Deurwaerd\u00e8re","year":"2016","journal-title":"Drugs Today (Barc)"},{"key":"10.1124\/jpet.119.259390_bib16","series-title":"Overshadowed by the opioid crisis: a comeback by cocaine","author":"Frakt","year":"2018"},{"key":"10.1124\/jpet.119.259390_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vascn.2011.03.001","article-title":"Continuous evaluation of drug withdrawal in the rat using telemetry: effects of morphine and chlordiazepoxide","volume":"64","author":"Froger-Coll\u00e9aux","year":"2011","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.119.259390_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00213-013-3254-y","article-title":"The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats","volume":"231","author":"Galaj","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.259390_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugalcdep.2015.11.030","article-title":"The dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference","volume":"159","author":"Galaj","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.119.259390_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2015.09.011","article-title":"The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats","volume":"156","author":"Galaj","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"13","key":"10.1124\/jpet.119.259390_bib80","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1124\/jpet.119.259390_bib21","doi-asserted-by":"crossref","first-page":"F914","DOI":"10.1152\/ajprenal.00380.2010","article-title":"Inhibition of renal caveolin-1 reduces natriuresis and produces hypertension in sodium-loaded rats","volume":"300","author":"Gildea","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.119.259390_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bmcl.2006.10.076","article-title":"Analogues of the dopamine D2 receptor antagonist L741,626: binding, function, and SAR","volume":"17","author":"Grundt","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.119.259390_bib23","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/HYPERTENSIONAHA.114.05096","article-title":"MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells","volume":"65","author":"Han","year":"2015","journal-title":"Hypertension"},{"key":"10.1124\/jpet.119.259390_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2017.05.014","article-title":"The cardiovascular effects of cocaine","volume":"70","author":"Havakuk","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/jpet.119.259390_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","article-title":"Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders","volume":"1187","author":"Heidbreder","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.119.259390_bib26","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.peptides.2005.10.012","article-title":"The cardiovascular responses to mu opioid agonist and antagonist in conscious normal and obese rats","volume":"27","author":"Hill-Pryor","year":"2006","journal-title":"Peptides"},{"key":"10.1124\/jpet.119.259390_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejphar.2013.10.026","article-title":"The dopamine D3 receptor antagonist YQA14 that inhibits the expression and drug-primed reactivation of morphine-induced conditioned place preference in rats","volume":"720","author":"Hu","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.259390_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1258\/la.2007.06002e","article-title":"Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats","volume":"42","author":"Ilb\u00e4ck","year":"2008","journal-title":"Lab Anim"},{"key":"10.1124\/jpet.119.259390_bib29","doi-asserted-by":"crossref","first-page":"107609","DOI":"10.1016\/j.neuropharm.2019.04.015","article-title":"Progress in agonist therapy for substance use disorders: lessons learned from methadone and buprenorphine","volume":"158","author":"Jordan","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.259390_bib30","doi-asserted-by":"crossref","first-page":"107597","DOI":"10.1016\/j.neuropharm.2019.04.003","article-title":"The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents","volume":"158","author":"Jordan","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.259390_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00041552-200201000-00013","article-title":"Role of dopamine receptors in the kidney in the regulation of blood pressure","volume":"11","author":"Jose","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1124\/jpet.119.259390_bib32","first-page":"R1325","article-title":"Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats","volume":"256","author":"Kannan","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.119.259390_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-420118-7.00007-X","article-title":"Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design","volume":"69","author":"Keck","year":"2014","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.119.259390_bib34","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1021\/jm501512b","article-title":"Identifying medication targets for psychostimulant addiction: unraveling the dopamine D3 receptor hypothesis","volume":"58","author":"Keck","year":"2015","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.259390_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fimmu.2016.00435","article-title":"Induction of dendritic cell maturation and activation by a potential adjuvant, 2-hydroxypropyl-\u03b2-cyclodextrin","volume":"7","author":"Kim","year":"2016","journal-title":"Front Immunol"},{"key":"10.1124\/jpet.119.259390_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-3565(25)12741-9","article-title":"Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats","volume":"255","author":"Kiritsy-Roy","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259390_bib37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.109.160432","article-title":"Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3\/D2 dopamine receptor antagonist\u2013partial agonist antipsychotic candidate: in vitro and neurochemical profile","volume":"333","author":"Kiss","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259390_bib38","doi-asserted-by":"crossref","first-page":"e85888","DOI":"10.1172\/jci.insight.85888","article-title":"Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure","volume":"1","author":"Konkalmatt","year":"2016","journal-title":"JCI Insight"},{"key":"10.1124\/jpet.119.259390_bib39","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/acs.jmedchem.6b00860","article-title":"Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the D3R crystal structure: new leads for opioid dependence treatment","volume":"59","author":"Kumar","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.259390_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev.ph.48.030186.003145","article-title":"Neurotransmitters in temperature control","volume":"48","author":"Lipton","year":"1986","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/jpet.119.259390_bib41","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V12112272","article-title":"Dopamine D3 receptors and salt-dependent hypertension","volume":"12","author":"Luippold","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.119.259390_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1369-1600.2008.00115.x","article-title":"Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women","volume":"13","author":"Lynch","year":"2008","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.119.259390_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neulet.2018.11.027","article-title":"Central nervous system circuits that control body temperature","volume":"696","author":"Madden","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.119.259390_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.114.214833","article-title":"Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys","volume":"350","author":"Martelle","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259390_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2018.12.006","article-title":"Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats","volume":"195","author":"McClenahan","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.119.259390_bib46","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jnc.13732","article-title":"Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter","volume":"138","author":"McGinnis","year":"2016","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.119.259390_bib47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0893-133X(99)00020-2","article-title":"Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle","volume":"21","author":"Mendelson","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.259390_bib48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1021\/jm901319p","article-title":"1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D3 receptor antagonists","volume":"53","author":"Micheli","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.259390_bib49","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1080\/07391102.2018.1513378","article-title":"Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity","volume":"37","author":"Montgomery","year":"2019","journal-title":"J Biomol Struct Dyn"},{"key":"10.1124\/jpet.119.259390_bib50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-201x.2000.00665.x","article-title":"Dopamine D3 receptors in the rat kidney: role in physiology and pathophysiology","volume":"168","author":"M\u00fchlbauer","year":"2000","journal-title":"Acta Physiol Scand"},{"key":"10.1124\/jpet.119.259390_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1476-5381.1961.tb01095.x","article-title":"Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen","volume":"16","author":"Muscholl","year":"1961","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1124\/jpet.119.259390_bib52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02253531","article-title":"Involvement of \u03b4-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice","volume":"111","author":"Narita","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.259390_bib53","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1021\/jm040190e","article-title":"Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents","volume":"48","author":"Newman","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.259390_bib54","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1369\/jhc.4A6359.2004","article-title":"Subapical localization of the dopamine D3 receptor in proximal tubules of the rat kidney","volume":"52","author":"N\u00fcrnberger","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/jpet.119.259390_bib55","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/01.HYP.32.5.886","article-title":"Expression of the dopamine D3 receptor protein in the rat kidney","volume":"32","author":"O\u2019Connell","year":"1998","journal-title":"Hypertension"},{"key":"10.1124\/jpet.119.259390_bib56","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0345-17.2018","article-title":"Locomotor- and reward-enhancing effects of cocaine are differentially regulated by chemogenetic stimulation of Gi-signaling in dopaminergic neurons","volume":"5","author":"Runegaard","year":"2018","journal-title":"eNeuro"},{"key":"10.1124\/jpet.119.259390_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(92)90238-Y","article-title":"Effects of cocaine and its quaternary derivative cocaine methiodide on cardiovascular function in squirrel monkeys","volume":"213","author":"Schindler","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.259390_bib58","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"10.1124\/jpet.119.259390_bib59","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b00607","article-title":"Investigation of novel primary and secondary pharmacophores, and 3-substitution in the linking chain of a series of highly selective and bitopic dopamine D3 receptor antagonists and partial agonists","author":"Shaik","year":"2019","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.119.259390_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.119.259390_bib61","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2013.10.010","article-title":"Blockade of D3 receptors by YQA14 inhibits cocaine\u2019s rewarding effects and relapse to drug-seeking behavior in rats","volume":"77","author":"Song","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.259390_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1369-1600.2011.00317.x","article-title":"YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice","volume":"17","author":"Song","year":"2012","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.119.259390_bib63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2013.04.042","article-title":"Dopamine D3 receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice","volume":"72","author":"Song","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.259390_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/156720211796558032","article-title":"Dopamine and vascular dynamics control: present status and future perspectives","volume":"8","author":"Tayebati","year":"2011","journal-title":"Curr Neurovasc Res"},{"key":"10.1124\/jpet.119.259390_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(25)39379-1","article-title":"Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system","volume":"267","author":"Tella","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.259390_bib66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(99)00582-8","article-title":"Cardiovascular responses to cocaine self-administration: acute and chronic tolerance","volume":"383","author":"Tella","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.259390_bib67","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/hc0902.104714","article-title":"Mechanism of the blood pressure\u2014raising effect of cocaine in humans","volume":"105","author":"Tuncel","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.119.259390_bib68","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn.2017.130","article-title":"The dopamine motive system: implications for drug and food addiction","volume":"18","author":"Volkow","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.119.259390_bib69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/acschemneuro.6b00297","article-title":"Dopamine D3\/D2 receptor antagonist PF-4363467 attenuates opioid drug-seeking behavior without concomitant D2 side effects","volume":"8","author":"Wager","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.119.259390_bib70","doi-asserted-by":"crossref","first-page":"F1164","DOI":"10.1152\/ajprenal.00604.2009","article-title":"Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II","volume":"299","author":"Wang","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.119.259390_bib71","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1097\/TP.0000000000000762","article-title":"Stimulation of dopamine D3 receptor attenuates renal ischemia-reperfusion injury via increased linkage with G\u03b112","volume":"99","author":"Wang","year":"2015","journal-title":"Transplantation"},{"key":"10.1124\/jpet.119.259390_bib72","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1021\/acschembio.8b00168","article-title":"Functionally biased D2R antagonists: targeting the \u03b2-arrestin pathway to improve antipsychotic treatment","volume":"13","author":"We\u00efwer","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1124\/jpet.119.259390_bib73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1369-1600.2012.00486.x","article-title":"Blockade of dopamine D3 receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in rats","volume":"18","author":"Xi","year":"2013","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.119.259390_bib74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0091-3057(91)90154-T","article-title":"Cocaine-induced locomotor activity in rats","volume":"39","author":"Yeh","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.119.259390_bib75","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41386-018-0284-5","article-title":"Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects","volume":"44","author":"You","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.259390_bib76","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.09.007","article-title":"The novel dopamine D3 receptor antagonists\/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats","volume":"126","author":"You","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.259390_bib77","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.0000240500.96746.ec","article-title":"Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells","volume":"99","author":"Zeng","year":"2006","journal-title":"Circ Res"},{"key":"10.1124\/jpet.119.259390_bib78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1042\/CS20070018","article-title":"The dopaminergic system in hypertension","volume":"112","author":"Zeng","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/jpet.119.259390_bib79","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cne.20557","article-title":"\u03bc-Opioid receptor mRNA expression in identified hypothalamic neurons","volume":"487","author":"Zheng","year":"2005","journal-title":"J Comp Neurol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524268373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524268373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.259390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:57:23Z","timestamp":1739973443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524268373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0022356524268373"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.259390","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.259390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}